Single-cell heterogeneity in Sézary syndrome

Sézary syndrome (SS) is an aggressive leukemic variant of cutaneous T-cell lymphoma (CTCL) with a median life expectancy of less than 4 years. Although initial treatment responses are often good, the vast majority of patients with SS fail to respond to ongoing therapy. We hypothesize that malignant...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Adv
Autors principals: Buus, Terkild Brink, Willerslev-Olsen, Andreas, Fredholm, Simon, Blümel, Edda, Nastasi, Claudia, Gluud, Maria, Hu, Tengpeng, Lindahl, Lise M., Iversen, Lars, Fogh, Hanne, Gniadecki, Robert, Litvinov, Ivan V., Persson, Jenny L., Bonefeld, Charlotte Menné, Geisler, Carsten, Christensen, Jan Pravsgaard, Krejsgaard, Thorbjørn, Litman, Thomas, Woetmann, Anders, Ødum, Niels
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2018
Matèries:
Lymphoid Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6113609/
https://ncbi.nlm.nih.gov/pubmed/30139925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018022608
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars